Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 9, 2000
Four-cycle high-dose therapy with hematopoietic support for metastatic breast cancer: no improvement in outcomes compared with single-course high-dose therapy
W W Hu, R S Negrin, K Stockerl-Goldstein, et al.
Bone Marrow Transplantation
|
July 15, 2009
Long-term follow-up of patients with diffuse large B-cell non-Hodgkin's lymphoma receiving purged autografts after induction failure
J E Benjamin, G L Chen, T M Cao, et al.
European Cells & Materials
|
May 23, 2019
A metaphyseal fracture rat model for mechanistic studies of osteoporotic bone healing
R M Wong, U Thormann, M H Choy, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 5, 2000
Pulmonary toxicity syndrome in breast cancer patients undergoing BCNU-containing high-dose chemotherapy and autologous hematopoietic cell transplantation
T M Cao, R S Negrin, K E Stockerl-Goldstein, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 5, 2002
Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease
M J Stuart, N S Chao, S J Horning, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1997
Influence of age on the outcome of 500 autologous bone marrow transplant procedures for hematologic malignancies
C R Kusnierz-Glaz, P G Schlegel, R M Wong, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 1, 1996
Influence of preparatory regimen and source of hematopoietic cells on outcome of autotransplantation for non-Hodgkin's lymphoma
K E Stockerl-Goldstein, S J Horning, R S Negrin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 4, 2000
Favorable treatment outcome in non-Hodgkin's lymphoma patients with "poor" mobilization of peripheral blood progenitor cells
K E Stockerl-Goldstein, S A Reddy, S F Horning, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 1, 1996
Paradoxical effect of thalidomide prophylaxis on chronic graft-vs.-host disease
N J Chao, P M Parker, J C Niland, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 26, 1999
Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease: effect on chronic graft-vs.-host disease and long-term survival
M Ross, G M Schmidt, J C Niland, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 9, 2000
Four-cycle high-dose therapy with hematopoietic support for metastatic breast cancer: no improvement in outcomes compared with single-course high-dose therapy
W W Hu, R S Negrin, K Stockerl-Goldstein, et al.
Bone Marrow Transplantation
|
July 15, 2009
Long-term follow-up of patients with diffuse large B-cell non-Hodgkin's lymphoma receiving purged autografts after induction failure
J E Benjamin, G L Chen, T M Cao, et al.
European Cells & Materials
|
May 23, 2019
A metaphyseal fracture rat model for mechanistic studies of osteoporotic bone healing
R M Wong, U Thormann, M H Choy, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 5, 2000
Pulmonary toxicity syndrome in breast cancer patients undergoing BCNU-containing high-dose chemotherapy and autologous hematopoietic cell transplantation
T M Cao, R S Negrin, K E Stockerl-Goldstein, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 5, 2002
Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease
M J Stuart, N S Chao, S J Horning, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1997
Influence of age on the outcome of 500 autologous bone marrow transplant procedures for hematologic malignancies
C R Kusnierz-Glaz, P G Schlegel, R M Wong, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 1, 1996
Influence of preparatory regimen and source of hematopoietic cells on outcome of autotransplantation for non-Hodgkin's lymphoma
K E Stockerl-Goldstein, S J Horning, R S Negrin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 4, 2000
Favorable treatment outcome in non-Hodgkin's lymphoma patients with "poor" mobilization of peripheral blood progenitor cells
K E Stockerl-Goldstein, S A Reddy, S F Horning, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 1, 1996
Paradoxical effect of thalidomide prophylaxis on chronic graft-vs.-host disease
N J Chao, P M Parker, J C Niland, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 26, 1999
Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease: effect on chronic graft-vs.-host disease and long-term survival
M Ross, G M Schmidt, J C Niland, et al.
Page
of 5